tiprankstipranks
Trending News
More News >
Compass Therapeutics (CMPX)
NASDAQ:CMPX
US Market

Compass Therapeutics (CMPX) Financial Statements

Compare
341 Followers

Compass Therapeutics Financial Overview

Compass Therapeutics's market cap is currently $384.43M. The company's EPS TTM is $-0.12; its P/E ratio is ―; Compass Therapeutics is scheduled to report earnings on May 8, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 850.00K$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit$ 850.00K$ -1.89M$ -1.90M$ -1.62M$ -2.40M
Operating Income$ -56.63M$ -50.36M$ -41.66M$ -81.88M$ -27.81M
EBITDA$ -54.87M$ -48.47M$ -37.39M$ -29.61M$ -25.32M
Net Income$ -49.38M$ -42.49M$ -36.80M$ -82.55M$ -29.50M
Balance Sheet
Cash & Short-Term Investments$ 126.72M$ 152.46M$ 186.61M$ 144.51M$ 47.08M
Total Assets$ 140.40M$ 156.88M$ 199.65M$ 153.76M$ 51.91M
Total Debt$ 6.63M$ 1.73M$ 2.94M$ 4.04M$ 9.33M
Net Debt$ -36.85M$ -22.50M$ -32.01M$ -140.48M$ -37.74M
Total Liabilities$ 15.17M$ 8.34M$ 18.01M$ 13.68M$ 11.97M
Stockholders' Equity$ 125.23M$ 148.54M$ 181.64M$ 140.08M$ 39.95M
Cash Flow
Free Cash Flow$ -44.90M$ -40.65M$ -34.34M$ -21.23M$ -26.91M
Operating Cash Flow$ -44.85M$ -40.62M$ -34.13M$ -19.67M$ -26.80M
Investing Cash Flow$ 46.77M$ 26.96M$ -151.20M$ -1.77M$ 38.00K
Financing Cash Flow$ 17.34M$ 2.94M$ 75.76M$ 118.61M$ 48.54M
Currency in USD

Compass Therapeutics Earnings and Revenue History

Compass Therapeutics Debt to Assets

Compass Therapeutics Cash Flow

Compass Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis